Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
12/12/2002 | WO2002024749A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
12/12/2002 | WO2002018557A3 Human kinases |
12/12/2002 | WO2002002775A3 Calpain protease 12 |
12/12/2002 | WO2001095922A1 Remedies for allergic diseases and process for producing the same |
12/12/2002 | WO2001093983A9 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/12/2002 | WO2001089568A9 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
12/12/2002 | WO2001066692A8 The device for cultivating cordyceps sinensis and method for cultivating it and the uses thereof |
12/12/2002 | WO2001038360A9 Novel hcv non-structural polypeptide |
12/12/2002 | WO2001027303A9 Adeno-associated virus vectors encoding factor viii and methods of using the same |
12/12/2002 | WO2000032152A3 Compositions and methods for regulating bacterial pathogenesis |
12/12/2002 | US20020188109 Expression vector for use transformation of yeast cells |
12/12/2002 | US20020188105 Gain of function mutations in ATP-dependent transposition proteins |
12/12/2002 | US20020187930 Substances and their uses |
12/12/2002 | US20020187541 Method for production of alpha-amylase in recombinant bacillus |
12/12/2002 | US20020187540 Cloning and characterization of a human adenylyl cyclase |
12/12/2002 | US20020187539 Nucleotide sequences coding polypeptide for use in flavonoid biosynthesis in plants |
12/12/2002 | US20020187537 Culture product; polypeptide |
12/12/2002 | US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis |
12/12/2002 | US20020187531 Process for recovering statin compounds from a fermentation broth |
12/12/2002 | US20020187530 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
12/12/2002 | US20020187527 Generation of nucleotide sequence which can be used as tools of gene therapy; obtain cells, transform with expression vector, recover transformed cells, detect methyltransferase expression and methylated nucleotide sequences |
12/12/2002 | US20020187525 Genetically engineered streptomyces for use in the generation of an enzymatic polypeptide for use in food processing or medicines |
12/12/2002 | US20020187523 Extracellular signaling molecules |
12/12/2002 | US20020187503 Concentration and purification of analytes using electric fields |
12/12/2002 | US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation |
12/12/2002 | US20020187486 Detection of preferential nucleotide sequences in sample; obtain target nucleic acid sample, incubate with nucleases, expose to probes, detect preferential nucleotide sequences |
12/12/2002 | US20020187472 Nucleotide sequences coding protein for use in the treatment of cancer |
12/12/2002 | US20020187157 Administering an amyloidogenic polypeptide or subsequence thereof to induces production of antibodies against the amyloidogenic polypeptide; treatment of Alzheimer's disease |
12/12/2002 | US20020187142 Crosslinking of these receptors with a bispecific molecule of the invention would lead to inhibition of the release of allergic mediators and amelioration of the symptoms of allergic diseases. |
12/12/2002 | US20020187140 Two novel human cathepsin proteins |
12/12/2002 | US20020187126 Using modified herpes simplex virus (HSV) having a defect in ICP27 (HSV Delta 27), wherein the cancer cell is resistant to anti-cancer therapy. |
12/12/2002 | US20020185557 Micromachined lysing device and method for performing cell lysis |
12/12/2002 | CA2449890A1 B7-related nucleic acids and polypeptides useful for immunomodulation |
12/12/2002 | CA2449885A1 Improved isoprenoid production |
12/12/2002 | CA2449670A1 Mutant forms of cholera holotoxin as an adjuvant |
12/12/2002 | CA2449663A1 Mutant forms of cholera holotoxin as an adjuvant |
12/12/2002 | CA2449482A1 Chds as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449281A1 Prmts as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449275A1 Dgks as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449136A1 Igs as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2448606A1 Nucleic acid-associated proteins |
12/12/2002 | CA2448444A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
12/12/2002 | CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2448256A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
12/12/2002 | CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
12/12/2002 | CA2446211A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
12/12/2002 | CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof |
12/12/2002 | CA2418477A1 Method and apparatus for the concentration of fluid-borne pathogens |
12/12/2002 | CA2412652A1 Remedies for allergic diseases and process for producing the same |
12/11/2002 | EP1264888A2 A modified fluorescent protein |
12/11/2002 | EP1264842A1 Novel proteins and novel genes encoding the same |
12/11/2002 | EP1263983A1 Process for preparing control samples of particles such as microorganisms and cells |
12/11/2002 | EP1263982A1 Phosphatidyl serine receptors and uses thereof |
12/11/2002 | EP1263974A1 Host-vector systems for the phosphate-regulated excess production of polypeptides in bacillus |
12/11/2002 | EP1263972A2 Methods for homologous recombination |
12/11/2002 | EP1263970A1 Identification of a dual specificity phosphatase: dusp-10 |
12/11/2002 | EP1263964A2 Recombinant hhv8 dna |
12/11/2002 | EP1263963A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
12/11/2002 | EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency |
12/11/2002 | EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
12/11/2002 | EP1263957A2 Human lipid binding protein 1 |
12/11/2002 | EP1263956A2 Human genes and gene expression products |
12/11/2002 | EP1263955A2 Polypeptides and nucleic acids encoding same |
12/11/2002 | EP1263954A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
12/11/2002 | EP1263948A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/11/2002 | EP1263944A2 Nucleic acids, proteins, and antibodies |
12/11/2002 | EP1263943A1 Protein c derivatives |
12/11/2002 | EP1263942A2 Variants with altered properties |
12/11/2002 | EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
12/11/2002 | EP1263937A2 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
12/11/2002 | EP1263925A2 Method of aerating yeast prior to pitching |
12/11/2002 | EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
12/11/2002 | EP1263787A2 G-protein coupled receptors |
12/11/2002 | EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
12/11/2002 | EP1263782A2 Leafy cotyledon2 genes and their uses |
12/11/2002 | EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer |
12/11/2002 | EP1263769A1 Dna molecules encoding a glutamate-gated chloride channel in drosophila melanogaster |
12/11/2002 | EP1263767A2 Beta netrin and uses thereof |
12/11/2002 | EP1263766A1 Adam polynucleotides, polypeptides, and antibodies |
12/11/2002 | EP1263452A2 Methods and compositions for generating angiostatin |
12/11/2002 | EP1263295A1 Foodstuffs containing mucorales fungi |
12/11/2002 | EP0807185B9 Antitumor preparations containing a lipoteichoic acid from steptococcus |
12/11/2002 | CN1384882A Fatty acid desaturase gene from plants |
12/11/2002 | CN1384881A Compositions and methods for non-targeted activation of endogenous genes |
12/11/2002 | CN1384880A L-pantolactone-hydrolase and method for producing D-pantolactone |
12/11/2002 | CN1384879A peroxidase genomic gene derived from ipomoea batatas and promoter thereof |
12/11/2002 | CN1384878A IREN protein, its preparation and use |
12/11/2002 | CN1384877A Rescue of mumps virus from cDNA |
12/11/2002 | CN1384875A Polypeptides having glucanotransferase activity and nucleic acids encoding same |
12/11/2002 | CN1384874A Method for cultivating cells, membrane module, utilziation of membrane module and reaction system for cultivation of said cells |
12/11/2002 | CN1384757A Method for down-regulating GDF-8 activity |
12/11/2002 | CN1384190A Fermentation process of proudcing L-glutamine and bacteria of producing L-glutamine |
12/11/2002 | CN1384189A Construction of genetically engineered bollworm synergy protein strain and its synergistic protein expression |
12/11/2002 | CN1384188A Prepn method of photosynthetic bacterial prepn |
12/11/2002 | CN1384187A Batch culture process of variant strain of Bacillus subtilis |
12/11/2002 | CN1095874C Method for treating fermentation liquor |
12/11/2002 | CN1095677C 化合物 Compound |
12/10/2002 | US6492577 Nucleic acids are useful in targeting gene expression to embryos or in modulating embryo development in plants |
12/10/2002 | US6492562 Invention also relates to novel intermediates and the resulting modified polyketides and antibiotics. |
12/10/2002 | US6492511 Isolation and identification of novel polymerases |